Related Experiment Video

Updated: Jun 19, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Toll-like receptors and NOD-like receptors in rheumatic diseases

William J McCormack1, Andrew E Parker, Luke A O'Neill

  • 1OPSONA Therapeutics Ltd, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James' Hospital, Dublin 8, Ireland. wmccormack@opsona.com

Arthritis Research & Therapy
|October 20, 2009
PubMed

Insights

The study identifies Toll-like receptors (TLRs) and NOD-like receptors (NLRs) as key players in inflammatory joint diseases like rheumatoid arthritis and gout. Targeting these receptors offers new therapeutic strategies beyond current biologics.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Proinflammatory cytokine production is crucial in infection and tissue injury.
  • Toll-like receptors (TLRs) and NOD-like receptors (NLRs) are key receptor families involved.
  • These receptors play significant roles in the pathology of various inflammatory joint diseases.

Purpose of the Study:

  • To examine the role of TLRs and NLRs in inflammatory joint diseases.
  • To highlight specific receptors implicated in conditions like rheumatoid arthritis and gout.
  • To explore novel therapeutic avenues targeting these inflammatory pathways.

Main Methods:

  • Review and analysis of existing literature on TLRs and NLRs in inflammatory joint diseases.
  • Identification of specific TLRs (e.g., TLR2, TLR4) and NLRs (e.g., Nalp3) implicated in disease pathology.
  • Correlation of receptor activity with cytokine production and disease manifestation.

Main Results:

  • TLRs, including TLR2 and TLR4, are implicated in rheumatoid arthritis, ankylosing spondylitis, lyme arthritis, and osteoarthritis.
  • Nalp3, a key NLR, is crucial for IL-1beta production and plays a significant role in gout.
  • These receptors are central to the inflammatory processes in diverse joint conditions.

Conclusions:

  • TLRs and NLRs are critical targets for understanding and treating inflammatory joint diseases.
  • Nalp3's role in gout highlights the specific involvement of NLRs in certain arthropathies.
  • Targeting these receptor families presents opportunities for developing small molecule inhibitors as alternatives to biologics.

More Related Videos

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...